These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 12718798)

  • 21. Rapamycin and curcumin induce apoptosis in primary resting B chronic lymphocytic leukemia cells.
    Hayun R; Okun E; Berrebi A; Shvidel L; Bassous L; Sredni B; Nir U
    Leuk Lymphoma; 2009 Apr; 50(4):625-32. PubMed ID: 19373661
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Antisense-mediated suppression of Bcl-2 highlights its pivotal role in failed apoptosis in B-cell chronic lymphocytic leukaemia.
    Pepper C; Thomas A; Hoy T; Cotter F; Bentley P
    Br J Haematol; 1999 Dec; 107(3):611-5. PubMed ID: 10583267
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Abnormal intracellular level of Bax in CD3+ cells from untreated B-cell chronic lymphocytic leukemia patients.
    Scamardella F; Maconi M; Albertazzi L; Gamberi B; Gugliotta L; Brini M
    Lab Hematol; 2006; 12(4):187-92. PubMed ID: 17118768
    [TBL] [Abstract][Full Text] [Related]  

  • 24. γ-Secretase inhibitor I induces apoptosis in chronic lymphocytic leukemia cells by proteasome inhibition, endoplasmic reticulum stress increase and notch down-regulation.
    Rosati E; Sabatini R; De Falco F; Del Papa B; Falzetti F; Di Ianni M; Cavalli L; Fettucciari K; Bartoli A; Screpanti I; Marconi P
    Int J Cancer; 2013 Apr; 132(8):1940-53. PubMed ID: 23001755
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A dual role for the anti-apoptotic Bcl-2 protein in cancer: mitochondria versus endoplasmic reticulum.
    Akl H; Vervloessem T; Kiviluoto S; Bittremieux M; Parys JB; De Smedt H; Bultynck G
    Biochim Biophys Acta; 2014 Oct; 1843(10):2240-52. PubMed ID: 24768714
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Sorafenib induces cell death in chronic lymphocytic leukemia by translational downregulation of Mcl-1.
    Huber S; Oelsner M; Decker T; zum Büschenfelde CM; Wagner M; Lutzny G; Kuhnt T; Schmidt B; Oostendorp RA; Peschel C; Ringshausen I
    Leukemia; 2011 May; 25(5):838-47. PubMed ID: 21293487
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Increased apoptosis in B-chronic lymphocytic leukemia cells as a result of cyclin D3 down regulation.
    Wang P; Pavletic ZS; Joshi SS
    Leuk Lymphoma; 2002 Sep; 43(9):1827-35. PubMed ID: 12685840
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Therapeutics targeting Bcl-2 in hematological malignancies.
    Ruefli-Brasse A; Reed JC
    Biochem J; 2017 Oct; 474(21):3643-3657. PubMed ID: 29061914
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The Bcl-2 family as a rational target for the treatment of B-cell chronic lymphocytic leukaemia.
    Capitani N; Baldari CT
    Curr Med Chem; 2010; 17(9):801-11. PubMed ID: 20156175
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Pharmacological inhibitors of NF-kappaB accelerate apoptosis in chronic lymphocytic leukaemia cells.
    Pickering BM; de Mel S; Lee M; Howell M; Habens F; Dallman CL; Neville LA; Potter KN; Mann J; Mann DA; Johnson PW; Stevenson FK; Packham G
    Oncogene; 2007 Feb; 26(8):1166-77. PubMed ID: 16924235
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Interferon-alpha-mediated prevention of in vitro apoptosis of chronic lymphocytic leukemia B cells: role of bcl-2 and c-myc.
    Chaouchi N; Wallon C; Taieb J; Auffredou MT; Tertian G; Lemoine FM; Delfraissy JF; Vazquez A
    Clin Immunol Immunopathol; 1994 Nov; 73(2):197-204. PubMed ID: 7923926
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Doxorubicin and a butyric acid derivative effectively reduce levels of BCL-2 protein in the cells of chronic lymphocytic leukemia patient.
    Rabizadeh E; Bairey O; Aviram A; Ben-Dror I; Shaklai M; Zimra Y
    Eur J Haematol; 2001 Apr; 66(4):263-71. PubMed ID: 11380606
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Progress in BCL2 inhibition for patients with chronic lymphocytic leukemia.
    Tam CS; Seymour JF; Roberts AW
    Semin Oncol; 2016 Apr; 43(2):274-9. PubMed ID: 27040706
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Retinoid-induced apoptosis in B-cell chronic lymphocytic leukaemia cells is mediated through caspase-3 activation and is independent of p53, the retinoic acid receptor, and differentiation.
    Pepper C; Ali K; Thomas A; Hoy T; Fegan C; Chowdary P; Kell J; Bentley P
    Eur J Haematol; 2002 Oct; 69(4):227-35. PubMed ID: 12431242
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Bcl-2 and Bax protein interaction in B-lymphocytes of peripheral blood in patients with chronic lymphocytic leukemia].
    Brajusković G; Orolicki SV; Cerović S; Usaj SK; Marjanović S; Romac S
    Vojnosanit Pregl; 2005 May; 62(5):357-63. PubMed ID: 15913039
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Role of the CD40 and CD95 (APO-1/Fas) antigens in the apoptosis of human B-cell malignancies.
    Wang D; Freeman GJ; Levine H; Ritz J; Robertson MJ
    Br J Haematol; 1997 May; 97(2):409-17. PubMed ID: 9163608
    [TBL] [Abstract][Full Text] [Related]  

  • 37. 4-arylcoumarin analogues of combretastatins stimulate apoptosis of leukemic cells from chronic lymphocytic leukemia patients.
    Billard C; Menasria F; Quiney C; Faussat AM; Finet JP; Combes S; Kolb JP
    Exp Hematol; 2008 Dec; 36(12):1625-33. PubMed ID: 18922614
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Inflammation and survival pathways: chronic lymphocytic leukemia as a model system.
    Chen LS; Balakrishnan K; Gandhi V
    Biochem Pharmacol; 2010 Dec; 80(12):1936-45. PubMed ID: 20696142
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Significance of phosphotyrosine proteins, Bcl-2 and p53 for apoptosis in resting B-chronic lymphocytic leukemia (CLL) cells.
    Laytragoon-Lewin N; Rossmann ED; Castro J; Mellstedt H
    Int J Cancer; 2002 Jan; 97(3):344-8. PubMed ID: 11774286
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Induction of apoptosis by monosaccharide butyrate stable derivatives in chronic lymphocytic leukemia cells.
    Santini V; Gozzini A; Scappini B; Caporale R; Zoccolante A; Rigacci L; Gelardi E; Grossi A; Alterini R; Ferrini PR
    Haematologica; 1999 Oct; 84(10):897-904. PubMed ID: 10509037
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.